Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Ovarian Cancer

Living reference work entry
First Online:
Received:
Accepted:
DOI: https://doi.org/10.1007/978-3-642-27841-9_4295-3
How to cite

Definition

The term ovarian cancer is used to describe a heterogeneous group of malignant tumors found in the ovary (there is also a wide assortment of benign tumors derived from the ovary). Ovarian cancer is the most lethal gynecological cancer in industrialized countries and is the sixth leading cause of cancer deaths in women worldwide. Ovarian cancer typically occurs in peri- and postmenopausal women, with an average of 54 years at diagnosis. Histologically, ovarian cancer is complex but can be broadly divided into epithelial ovarian cancer, which accounts for up to 90 % of all the ovarian malignancies, and non-epithelial tumors (sex-cord stromal tumors and ovarian germ cell tumors). Epithelial ovarian tumors have been assumed to be derived from the ovarian surface epithelium, but new evidence suggests that some of these tumors may actually originate from extraovarian tissues, such as the fallopian tube epithelium and endometrial tissue.

Characteristics

Pathology

Epithelial ovarian...

Keywords

Ovarian Cancer Epithelial Ovarian Cancer Lynch Syndrome Ovarian Surface Epithelium Ovarian Cancer Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

References

  1. Badgwell D, Bast RC Jr (2007) Early detection of ovarian cancer. Dis Markers 23:397–410CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bhoola S, Hoskins WJ (2006) Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 107:1399–1410CrossRefPubMedGoogle Scholar
  3. Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:433–443CrossRefPubMedPubMedCentralGoogle Scholar
  4. Landen CN Jr, Birrer MJ, Sood AK (2008) Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26(6):995–1005Google Scholar
  5. Markman M (2008) Pharmaceutical management of ovarian cancer: current status. Drugs 68:771–789CrossRefPubMedGoogle Scholar
  6. Ozols R (2003) Ovarian cancer, 1st edn. BC Decker, LondonGoogle Scholar
  7. Scully RE (1999) Histological typing of ovarian tumors, 2nd edn. Springer, HeidelbergCrossRefGoogle Scholar

See Also

  1. (2012) Atypia. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 303. doi:10.1007/978-3-642-16483-5_449Google Scholar
  2. (2012) CA125. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 577–578. doi:10.1007/978-3-642-16483-5_761Google Scholar
  3. (2012) Carboplatin. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 641. doi:10.1007/978-3-642-16483-5_833Google Scholar
  4. (2012) Choriocarcinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 825. doi:10.1007/978-3-642-16483-5_6908Google Scholar
  5. (2012) Endometrioid Carcinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1234. doi:10.1007/978-3-642-16483-5_6966Google Scholar
  6. (2012) Epithelial Ovarian Cancer. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1292. doi:10.1007/978-3-642-16483-5_6952Google Scholar
  7. (2012) DNA Repair. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1141. doi:10.1007/978-3-642-16483-5_1687Google Scholar
  8. (2012) Dysgerminoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1177. doi:10.1007/978-3-642-16483-5_1759Google Scholar
  9. (2012) HE4. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1636. doi:10.1007/978-3-642-16483-5_6998Google Scholar
  10. (2012) Monoclonal Antibody. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2367. doi:10.1007/978-3-642-16483-5_6842Google Scholar
  11. (2012) Ovarian Clear Cell Carcinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2711. doi:10.1007/978-3-642-16483-5_6965Google Scholar
  12. (2012) Progression-Free Survival. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3001. doi:10.1007/978-3-642-16483-5_6496Google Scholar
  13. (2012) Sertoli-Leydig Cell Tumor. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3390. doi:10.1007/978-3-642-16483-5_5266Google Scholar
  14. (2012) Sex-Cord Stromal Tumors. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 3395-3396. doi:10.1007/978-3-642-16483-5_5273Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.National Institute on Aging, NIHBaltimoreUSA
  2. 2.Laboratory of Cellular and Molecular BiologyNational Institute on Aging, NIHBaltimoreUSA